Nakamura Akira

ナカムラアキラ | Nakamura Akira

Affiliation and department：

Research field (3)： Immunology , Experimental pathology , Respiratory medicine

Research keywords (6)： serine protease inhibitor , セリンプロテアーゼインヒビター , Fc receptor , Fc受容体 , immunoglobulin-like receptor , 免疫グロブリン様受容体

Research theme for competitive and other funds (20)：

Show all

Papers (56)：

Atsuya Sawabe, Shogo Okazaki, Akira Nakamura, Ryo Goitsuka, Tomonori Kaifu. The orphan G protein-coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor. Journal of leukocyte biology. 2024
Kazuya Takeda, Tomonori Kaifu, Ryunosuke Michihata, Naotaka Kinugawa, Atushi Fujioka, Ayaka Tateno, Kaoru Toshima, Hirotaka Kanoh, Kei-Ichiro Inamori, Keiju Kamijo, et al. Chronic encephalomyelitis virus exhibits cellular tropism and evades pDCs by binding to sialylated integrins as the cell surface receptors. European Journal of Immunology. 2023
Tomonori Kaifu, Takumi Maruhashi, Soo-Hyun Chung, Kenji Shimizu, Akira Nakamura, Yoichiro Iwakura. DCIR suppresses osteoclastic proliferation and resorption by downregulating M-CSF and RANKL signaling. Frontiers in immunology. 2023. 14. 1159058-1159058
Yuki Kohada, Akito Kuromoto, Kazuya Takeda, Hiromichi Iwamura, Yuri Atobe, Jun Ito, Tomonori Kaifu, Yasuhiro Kaiho, Ichiro Nakashima, Nobuyuki Hinata, et al. Circulating PMN-MDSC level positively correlates with a poor prognosis in patients with metastatic hormone-sensitive prostate cancer. Frontiers in Urology. 2022. 2
Akito Morimoto, Junichi Kikuta, Keizo Nishikawa, Takao Sudo, Maki Uenaka, Masayuki Furuya, Tetsuo Hasegawa, Kunihiko Hashimoto, Hiroyuki Tsukazaki, Shigeto Seno, et al. SLPI is a critical mediator that controls PTH-induced bone formation. Nature Communications. 2021. 12. 1. 2136-2136

ｍore...

MISC (92)：

小羽田悠貴, 黒本暁人, 武田和也, 楠本大樹, 三上穣太郎, 伊藤淳, 海法康裕, 中村保宏, 中村晃, 佐藤信. PSA低値、CEA高値を来した去勢抵抗性前立腺癌の1例. 泌尿器外科. 2022. 35. 4. 353-353
吉村成央, 海部知則, 武田和也, 跡部百合, 佐々木高信, 菅原崇史, 大類孝, 中村晃. Dynamic alteration of peripheral immune cells in patients with advanced NSCLC received anti-PD-1 therapy and clinical efficacy. 日本呼吸器学会誌(Web). 2021. 10
海部知則, 武田和也, 岩倉洋一郎, 中村晃. C型レクチン受容体欠損による中枢神経系自己免疫疾患自然発症機序の解明. 日本実験動物学会総会講演要旨集(Web). 2020. 67th
海部知則, 武田和也, 岩倉洋一郎, 中村晃. 中枢神経系自己免疫疾患自然発症動物モデルの開発. 日本実験動物学会総会講演要旨集(Web). 2019. 66th
吉村成央, 高橋秀徳, 黒澤恵美子, 海老名雅仁, 中村晃, 大類孝. ペンプロリズマブにより早期に高度のPseudo progressionを認めた肺腺癌の1例の臨床像と免疫学的検討. 肺癌. 2018. 58. 6. 702-702

ｍore...

Patents (5)：

Books (4)：

標準免疫学
医学書院 2013
内科診断学
医学書院 2010
Multichain Immune Recognition Receptor Signaling: From Spatiotemporal Organization to Human Disease
Landes bioscience 2008
Activating and Inhibitory Immunoglobulin-Like Receptors
Springer-Verlag Tokyo 2001

Lectures and oral presentations (2)：

TLR signals posttranscriptionally regulate the cytokine trafficking mediator sortilin
(Gordon Research Conference on Protein Processing, Trafficking and Secretion 2016)
Development of high sensitivity in vitro assessment system of chemical- mediated hypersensitivity by using serine protease inhibitor-deficient cells
(International Council of Chemical Associations' Long-Range Research Initiative Workshop 2016)

Education (2)：

Professional career (1)：

Work history (10)：

Show all

Committee career (3)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page